{"id":"https://openalex.org/W2885641865","doi":"https://doi.org/10.1158/1538-7445.am2018-3855","title":"Abstract 3855: Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response","display_name":"Abstract 3855: Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2885641865","doi":"https://doi.org/10.1158/1538-7445.am2018-3855","mag":"2885641865"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-3855","doi":"https://doi.org/10.1158/1538-7445.am2018-3855","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3855","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072719797","display_name":"Craig R. Stumpf","orcid":"https://orcid.org/0000-0002-9946-8986","observed_orcids":["https://orcid.org/0000-0002-9946-8986"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig R. Stumpf","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101888155","display_name":"Joan W. Chen","orcid":"https://orcid.org/0000-0002-1042-6932","observed_orcids":["https://orcid.org/0000-0002-1042-6932"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan Chen","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038860439","display_name":"Vikas Goel","orcid":"https://orcid.org/0000-0002-8659-1045","observed_orcids":["https://orcid.org/0000-0002-8659-1045"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vikas K. Goel","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036904532","display_name":"Gregory S. Parker","orcid":"https://orcid.org/0009-0003-7468-5700","observed_orcids":["https://orcid.org/0009-0003-7468-5700"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory S. Parker","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071873704","display_name":"Gary Gene Chiang","orcid":"https://orcid.org/0000-0003-3004-7400","observed_orcids":["https://orcid.org/0000-0003-3004-7400"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary G. Chiang","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108099174","display_name":"Peggy A. Thompson","orcid":"https://orcid.org/0009-0009-9194-5870","observed_orcids":["https://orcid.org/0009-0009-9194-5870"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peggy A. Thompson","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075615241","display_name":"Kevin R. Webster","orcid":"https://orcid.org/0000-0002-6776-9055","observed_orcids":["https://orcid.org/0000-0002-6776-9055"]},"institutions":[{"id":"https://openalex.org/I4405272897","display_name":"eFFECTOR Therapeutics (United States)","ror":"https://ror.org/04y222144","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin R. Webster","raw_affiliation_strings":["eFFECTOR Therapeutics, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eFFECTOR Therapeutics, San Diego, CA","institution_ids":["https://openalex.org/I4405272897"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405272897"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"3855","last_page":"3855"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6449999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6449999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.13449999690055847,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.07530000060796738,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mnk1","display_name":"MNK1","score":0.8889999985694885},{"id":"https://openalex.org/keywords/mnk2","display_name":"MNK2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.6800000071525574},{"id":"https://openalex.org/keywords/t-cell-receptor-signaling","display_name":"T cell receptor signaling","score":0.8149999976158142},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8339999914169312},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.8709999918937683},{"id":"https://openalex.org/keywords/eif4e-phosphorylation","display_name":"eIF4E phosphorylation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/immune-checkpoint-receptors","display_name":"immune checkpoint receptors","score":0.7599999904632568},{"id":"https://openalex.org/keywords/post-transcriptional-regulation","display_name":"post-transcriptional regulation","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cd3-cd28-costimulation","display_name":"anti-CD3/CD28 stimulation","score":0.8029999732971191},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.671028196811676},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6540635824203491},{"id":"https://openalex.org/C6675166","wikidata":"https://www.wikidata.org/wiki/Q7187538","display_name":"Phosphoproteomics","level":5,"score":0.6161441802978516},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.6126095652580261},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5921512246131897},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5839069485664368},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5509507060050964},{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.5443486571311951},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4941289722919464},{"id":"https://openalex.org/C150555746","wikidata":"https://www.wikidata.org/wiki/Q210973","display_name":"Cell signaling","level":3,"score":0.493477463722229},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.46150994300842285},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4298168420791626},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.419556200504303},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.34153467416763306},{"id":"https://openalex.org/C87325107","wikidata":"https://www.wikidata.org/wiki/Q7251493","display_name":"Protein phosphorylation","level":4,"score":0.3153429925441742},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1871306300163269},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1466342806816101}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-3855","doi":"https://doi.org/10.1158/1538-7445.am2018-3855","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3855","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6299999952316284,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2170736411","https://openalex.org/W2373950388","https://openalex.org/W2382568157","https://openalex.org/W2095232949","https://openalex.org/W2911789102","https://openalex.org/W1973530967","https://openalex.org/W2104107382","https://openalex.org/W2060747252","https://openalex.org/W2350530498","https://openalex.org/W2053235095"],"abstract_inverted_index":{"Abstract":[0],"Mitogen-activated":[1],"protein":[2],"(MAP)":[3],"kinase":[4],"signaling":[5,38,238,323,376],"cascades":[6],"play":[7],"a":[8,83,198,268],"vital":[9],"role":[10],"in":[11,25,32,235,264,285,301],"T-cell":[12,118,148,204,237,375],"activation":[13],"upon":[14],"antigen":[15],"recognition.":[16,274],"MNK1":[17,90,297,325],"and":[18,42,79,85,91,126,152,242,247,249,300,326,328],"MNK2":[19,92,299,327],"are":[20,47,121,233],"important":[21,37,236],"downstream":[22],"effector":[23],"kinases":[24],"the":[26,34,52,62,65,74,103,129,144,219,261,387],"MAPK":[27],"pathway":[28],"that":[29,93,120],"largely":[30],"function":[31],"regulating":[33],"expression":[35,53,104],"of":[36,54,64,89,105,131,140,147,200,221,276,279,290,293,321,339,370,386],"molecules,":[39,107],"including":[40],"cytokines":[41],"immune":[43,110,381],"checkpoint":[44,111],"receptors.":[45,112],"MNKs":[46,340],"primarily":[48],"thought":[49],"to":[50,97,115,168,331,377],"regulate":[51],"select":[55,225],"mRNAs,":[56],"predominantly":[57],"via":[58],"post-transcriptional":[59,248],"mechanisms":[60],"involving":[61],"phosphorylation":[63,125,220,262,278,292],"eukaryotic":[66],"translation":[67],"initiation":[68],"factor":[69],"eIF4E":[70],"as":[71,73,109],"well":[72],"RNA":[75],"binding":[76],"proteins":[77],"hnRNPA1":[78],"PSF.":[80],"eFT508":[81,132,154,163,216,231,306,342,373],"is":[82,282],"potent":[84],"highly":[86],"selective":[87],"inhibitor":[88],"has":[94],"been":[95],"shown":[96],"promote":[98,378],"antitumor":[99,345,380],"immunity":[100],"by":[101,123,186,230,287,296,307,341,372],"decreasing":[102],"immunosuppressive":[106],"such":[108],"In":[113],"order":[114],"identify":[116],"key":[117],"components":[119],"regulated":[122],"MNK":[124,272,371],"may":[127],"mediate":[128],"effects":[130],"treatment,":[133],"we":[134],"performed":[135],"an":[136,173,379],"unbiased":[137],"phosphoproteomic":[138,184],"analysis":[139,185,289,310],"T":[141,158,196],"cells":[142,159],"during":[143],"early":[145],"stages":[146],"receptor-mediated":[149],"stimulation":[150,169],"with":[151,162,170,190,203,215,305],"without":[153],"treatment.":[155],"Primary":[156],"human":[157],"were":[160,179,211],"pretreated":[161],"for":[164,172,182,257,390],"two":[165],"hours":[166],"prior":[167],"\u03b1CD3/\u03b1CD28":[171],"additional":[174],"30":[175],"minutes.":[176],"Protein":[177],"samples":[178],"then":[180],"prepared":[181],"multiplexed":[183],"mass":[187],"spectrometry.":[188],"Consistent":[189],"previous":[191],"proteomic":[192],"studies":[193],"using":[194,311],"stimulated":[195],"cells,":[197],"number":[199],"phosphopeptides":[201],"associated":[202],"receptor":[205],"signaling,":[206],"among":[207],"other":[208],"cellular":[209,302],"activities,":[210],"detected.":[212],"Moreover,":[213],"treatment":[214,232],"specifically":[217],"blocked":[218],"distinct":[222],"phosphosites":[223],"on":[224],"proteins.":[226],"The":[227],"phosphoproteins":[228],"modulated":[229],"involved":[234],"pathways,":[239],"cell":[240,322],"proliferation":[241],"differentiation":[243],"programs,":[244],"stress":[245],"responses,":[246],"translational":[250],"gene":[251],"regulation.":[252],"Furthermore,":[253],"there":[254],"was":[255],"enrichment":[256],"specific":[258],"sequences":[259],"surrounding":[260],"site":[263],"eFT508-sensitive":[265],"peptides,":[266],"highlighting":[267],"potential":[269,294,333],"mechanism":[270],"mediating":[271],"target":[273],"Confirmation":[275],"MNK-mediated":[277],"novel":[280],"substrates":[281,295],"being":[283],"conducted":[284],"vitro":[286],"biochemical":[288],"direct":[291],"or":[298],"lysates":[303],"treated":[304],"Western":[308],"blot":[309],"phosphosite-specific":[312],"antibodies.":[313],"These":[314],"findings":[315],"have":[316],"significantly":[317],"expanded":[318],"our":[319],"understanding":[320],"through":[324,336],"will":[329],"help":[330],"illuminate":[332],"regulatory":[334],"programs":[335],"which":[337],"inhibition":[338],"can":[343],"modulate":[344],"immunity.":[346],"Citation":[347],"Format:":[348],"Craig":[349],"R.":[350,367],"Stumpf,":[351],"Joan":[352],"Chen,":[353],"Vikas":[354],"K.":[355],"Goel,":[356],"Gregory":[357],"S.":[358],"Parker,":[359],"Gary":[360],"G.":[361],"Chiang,":[362],"Peggy":[363],"A.":[364],"Thompson,":[365],"Kevin":[366],"Webster.":[368],"Inhibition":[369],"reprograms":[374],"response":[382],"[abstract].":[383],"In:":[384],"Proceedings":[385],"American":[388],"Association":[389],"Cancer":[391,404],"Research":[392],"Annual":[393],"Meeting":[394],"2018;":[395],"2018":[396],"Apr":[397],"14-18;":[398],"Chicago,":[399],"IL.":[400],"Philadelphia":[401],"(PA):":[402],"AACR;":[403],"Res":[405],"2018;78(13":[406],"Suppl):Abstract":[407],"nr":[408],"3855.":[409]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2025-10-10T00:00:00"}